Navigating the complexities of drug development for metallo-β-lactamase inhibitors
RSC Medicinal Chemistry · 2025 · 16 (8) · 3393-3415
DOI: 10.1039/d5md00035a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Nakita Reddy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Catalysis and Peptide Research Unit, University of KwaZulu-Natal Durban 4000 South Africa naickert1@ukzn.ac.za. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, South African Medical Research Council.
Abstract (Originalsprache)
Standardized approaches to MBL inhibitor development are vital. This work highlights the benefits of uniform methodologies while addressing key preclinical challenges to bridge the gap toward successful clinical translation.
Autor:innen und Institutionen
- Catalysis and Peptide Research Unit, University of KwaZulu-Natal Durban 4000 South Africa naickert1@ukzn.ac.za.
- Office of AIDS and TB, South African Medical Research Council Pretoria 0084 South Africa.
- Laboratory of Computer Modeling of Molecular Biosystems, Federal University of Pará Belém 66075-110 Pará Brazil.
- Science for Life Laboratory, Drug Discovery & Development Platform & Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet Stockholm 17177 Swed…
- Department of Chemistry, University of Zululand Private Bag X1001 KwaDlangezwa 3886 South Africa govenderthav@icloud.com.
ORCID-Profile: Nakita Reddy, Alessandra Moraes Balieiro, José Rogério A Silva, Awelani Mutshembele, Per I Arvidsson, Hendrik G Kruger, Tricia Naicker
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- South African Medical Research Council
- National Research Foundation
Zitieren
APA
Reddy, N., Balieiro, A. M., Silva, J. R. A., Gouws, C. A., Mutshembele, A., Arvidsson, P. I., Kruger, H. G., Govender, T., & Naicker, T. (2025). Navigating the complexities of drug development for metallo-β-lactamase inhibitors. RSC Medicinal Chemistry, 16(8), 3393-3415. https://doi.org/10.1039/d5md00035a
Vancouver
Reddy N, Balieiro AM, Silva JRA, Gouws CA, Mutshembele A, Arvidsson PI, et al. Navigating the complexities of drug development for metallo-β-lactamase inhibitors. RSC Medicinal Chemistry. 2025;16(8):3393-3415. doi:10.1039/d5md00035a
BibTeX
@article{Reddy2025,
author = {Reddy, Nakita and Balieiro, Alessandra Moraes and Silva, José Rogério A and Gouws, Christiaan A and Mutshembele, Awelani and Arvidsson, Per I and Kruger, Hendrik G and Govender, Thavendran and Naicker, Tricia},
title = {Navigating the complexities of drug development for metallo-β-lactamase inhibitors},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {8},
pages = {3393--3415},
doi = {10.1039/d5md00035a}
}
EUVIMED